The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival

The International Prognostic Index and the Follicular Lymphoma International Prognostic Index are widely used for the risk assessment of follicular lymphoma (FL). Although molecular studies have provided insight into the biology of FL, no molecular marker has impacted on treatment stratification. Be...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: O'Shea, Derville, O'Riain, Ciarán, Taylor, Claire, Waters, Rachel, Carlotti, Emanuela, MacDougall, Finlay, Gribben, John, Rosenwald, Andreas, Ott, German, Rimsza, Lisa M., Smeland, Erlend B., Johnson, Nathalie, Campo, Elias, Greiner, Timothy C., Chan, Wing C., Gascoyne, Randy D., Wright, George, Staudt, Louis M., Lister, T. Andrew, Fitzgibbon, Jude
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Hematology 2008
Témata:
Clinical Trials and Observations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2954748/
https://ncbi.nlm.nih.gov/pubmed/18628487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-05-154013
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky